http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170022598-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89063d5fcadc27223898e77276bc70d8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_547be0bc725b191dd4b5af56633d348d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39404387c2274d7aedc230b82ff1e189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15bce25903809d138ad9319d4991ea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482a40d635224a8eb345dc09f843ab9c
publicationDate 2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20170022598-A
titleOfInvention Method for solubilizing Rebamipide and a solution for treating dry eye syndrome prepared thereby
abstract (A) dissolving rebamipide or a pharmaceutically acceptable salt, cyclodextrin or cyclodextrin derivative thereof, and a base in water to obtain a solution having a pH of at least 8.5; And (b) adjusting the pH of the solution obtained in step (a) to a pH of 7 to 8.5, and a solution for treating dry eye syndrome produced by the method. Not only is rebamipide completely dissolved in a clear aqueous solution state by the solubilizing method of the present invention, the liquid preparation produced by the solubilizing method maintains a stable solution formulation even after 2 months in the accelerated test, And improved bioavailability with increasing absorption and persistence of rebamipide in conjunctiva. Therefore, the aqueous solution prepared by the solubilization method of the present invention can be effectively used as a solution for treating dry eye syndrome including rebamipide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230011669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022092896-A1
priorityDate 2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140113629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110010712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070092965-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090073248-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415152033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449949725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453375181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12856218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447980235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424657118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553082

Total number of triples: 62.